Reactivation of DRP1 plays a functional role in resistance to MEK inhibition in pancreatic cancer cells
Salma Sharmin, Jennifer A. Kashatus, Sara J. Adair, Emma Bakall Loewgren, Mohammad Fallahi‐Sichani, Todd W. Bauer, David F. Kashatus
This study identifies DRP1 reactivation as a mechanism of resistance to MEK inhibition in pancreatic cancer cells and shows that inhibiting DRP1 can restore sensitivity to trametinib.
British Journal of Cancer · Jul 14, 2026Peer-reviewedCancer Biology